BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 61 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,000 | -52.4% | 40,604 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $21,000 | -73.4% | 40,604 | +5.2% | 0.00% | -62.5% |
| Q1 2022 | $79,000 | -50.9% | 38,604 | 0.0% | 0.01% | -50.0% |
| Q4 2021 | $161,000 | -55.2% | 38,604 | 0.0% | 0.02% | -60.0% |
| Q3 2021 | $359,000 | -54.8% | 38,604 | -12.5% | 0.04% | -54.0% |
| Q2 2021 | $795,000 | – | 44,116 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |